Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019)
Theravance Biopharma (TBPH) posted quarterly Change in Receivables of -$86000.0 for Q4 2019, up 96.42% year-over-year from -$43783.1 in Q4 2018, and up 40.69% quarter-over-quarter from -$145000.0 in Q3 2019.
Theravance Biopharma (TBPH) Change in Receivables (2013 - 2019) Analysis & Trends
Theravance Biopharma (TBPH) has reported Change in Receivables for 7 consecutive years, with -$86000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Change in Receivables rose 96.42% year-over-year to -$86000.0; the TTM figure through Dec 2019 stood at -$620000.0 (up 62.03% YoY), while the FY2019 annual figure was -$620000.0, up 62.03% from the prior year.
- Change in Receivables rose to -$86000.0 in Q4 2019 per TBPH's latest filing, from -$145000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.5 million in Q2 2018 and bottomed at -$2.4 million in Q4 2018.
- Historically, Change in Receivables has averaged -$14450.0 across 5 years, with a median of $45500.0 in 2015.
- Annual changes were most pronounced in 2016 — Change in Receivables slumped 4368.18% — and 2018, when it soared 1192.92%.
- Theravance Biopharma's Change in Receivables stood at $1.1 million in 2015, then sank by 119.93% to -$227000.0 in 2016, then jumped by 398.24% to $677000.0 in 2017, then tumbled by 455.1% to -$2.4 million in 2018, then jumped by 96.42% to -$86000.0 in 2019.
- Business Quant data shows TBPH's Change in Receivables at -$86000.0 in Q4 2019, -$145000.0 in Q3 2019, and $118000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -86,000.00 |
| Dec 31, 2019 | -86,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Sep 30, 2019 | -145,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Jun 30, 2019 | 118,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Mar 31, 2019 | -507,000.00 |
| Dec 31, 2018 | -2.40 Mn |
| Dec 31, 2018 | -2.40 Mn |
| Sep 30, 2018 | -410,000.00 |
| Sep 30, 2018 | -410,000.00 |
| Jun 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | -280,000.00 |
| Mar 31, 2018 | -280,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Dec 31, 2017 | 677,000.00 |
| Sep 30, 2017 | 230,000.00 |
| Sep 30, 2017 | 230,000.00 |